Clinical Trials Directory

Trials / Completed

CompletedNCT01943539

Cognitive ADHD Videogame Exploratory Study

A Study to Assess the Feasibility of EVO Gameplay to Engage Children With Attention Deficit Hyperactivity Disorder (ADHD) and to Evaluate Cognitive Interference in Children Ages 8 to 12 Years Old With ADHD Compared to Neuro-typical Children

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
84 (actual)
Sponsor
Akili Interactive Labs, Inc. · Industry
Sex
All
Age
8 Years – 12 Years
Healthy volunteers
Accepted

Summary

A study in ADHD and neuro-typical children to assess EVO game play over 29 days.

Detailed description

A study in children ages 8 to 12 to assess EVO cognitive game play. The study examines two populations, children diagnosed with ADHD (ADHD and not on medication) and neuro-typical children. The investigators plan to evaluate 80 subjects (N = 40 per group) in three site locations over a 29 day study period. The 29 day study period includes 2 in-clinic sessions and 27 days of out-patient game play. During the 27 days of out-patient game play, the subjects will be instructed to play EVO 5 days per week for typically 30 minutes per day The investigators' hypothesis is that EVO will be playable and interesting to ADHD children and cognitive measures, as captured by EVO, will show a difference between ADHD children and age-matched neuro-typical children.

Conditions

Interventions

TypeNameDescription
DEVICENeuro-typical controls and ADHD will receive EVO game play.EVO mobile video application

Timeline

Start date
2013-09-01
Primary completion
2015-05-01
Completion
2015-05-01
First posted
2013-09-17
Last updated
2017-12-13
Results posted
2017-12-13

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01943539. Inclusion in this directory is not an endorsement.